Research
Explore the Data
Organizations
People
Investors
Locations
Papers
Clinical Trials
Stock Market
Industry Reports
EDU
Courses
Events
Jobs
News
Podcasts
Articles
Books
Videos
Care
Find a Ketamine Clinic
Psilocybin in Oregon
Find a Retreat
Telehealth Treatments
Participate in a Clinical Trial
Login
Register
Light Mode
Dark Mode
Auto
Neuly
People
Tim Schlidt
Tim Schlidt
https://www.palosanto.vc
Articles / Podcasts / Other Media
The Psychedelics Finance Crunch Seen in the SXSW Funhouse Mirror
When I last came to SXSW, Austin’s high rent version of Mardi Gras, in the ancient mid 90s, it was all about the bands. Times...
Article
Mar 19, 2023
Where Did 2022 Take the Psychedelic Medicine Field?
Josh Hardman, the founder of Psychedelic Alpha, reviews the published findings of COMPASS Pathways’ Phase 2b clinical trial and its upcoming Phase 3 program. Psychedelic...
Article
Feb 21, 2023
Gilgamesh Tweaks Known Psychedelics To Improve Therapies
Many startup companies developing psychedelic therapies work with classic mind-altering substances such as psilocybin, mescaline and LSD. Jonathan Sporn, the founder and chief executive of...
Article
Jan 30, 2023
Tim Schlidt is Funding a New Paradigm in Wellbeing – Podcast Episode #22
On this episode of the Psychedelic Invest Podcast, we welcome Tim Schlidt of Palo Santo. Palo Santo is a leading therapeutics investment fund dedicated to...
Article
Oct 19, 2022
Tim Schlidt is Funding a New Paradigm in Wellbeing
On this episode of the Psychedelic Invest Podcast, we welcome Tim Schlidt of Palo Santo. Palo Santo is a leading therapeutics investment fund dedicated to...
Podcast
Oct 18, 2022
Investors
Palo Santo
Managing Partner
Last updated: Oct 18, 2022
Request Deletion
Update this listing